| Financial Year |
March 31 2023 |
| Monetary Funds |
906,678,898.28 |
| Held-for-trading Financial Assets |
70,960,753.42 |
| Notes Receivable |
228,137,539.33 |
| Accounts Receivable |
596,281,293.44 |
| Advances to Suppliers |
33,118,275.91 |
| Other Receivables |
158,027,171.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,407,187,723.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,835,760.42 |
| Total Current Assets |
3,704,559,014.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,836,546.64 |
| Long-term Equity Investment |
30,108,212.57 |
| Investment Properties |
67,160,132.52 |
| Fixed Assetes |
4,641,339,378.12 |
| Under-construction Projects |
881,428,266.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
757,210,042.04 |
| R&D expenses |
114,077,890.68 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
17,281,426.58 |
| Deferred Income Tax Assets |
385,156,927.02 |
| Other Non-Current Assets |
97,204,343.93 |
| Sub-Total of Non-Current Assets |
7,001,781,073.07 |
| Total Assets |
10,706,340,087.43 |
| Short-Term Loans |
1,509,358,395.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
250,565,914.95 |
| Accounts Payable |
534,711,742.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,635,110.63 |
| Taxes Payable |
13,985,531.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,207,375.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
724,587,814.85 |
| Other Current Liabilities |
93,131,003.88 |
| Sub-Total of Current Liabilities |
3,212,218,883.80 |
| Long-term Loans |
852,662,246.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
16,546,016.04 |
| Special Payable |
-- |
| Estimatied Liabilities |
3,580,000.00 |
| Deferred Income Tax Liabilities |
178,019,586.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,308,244,250.66 |
| Total Liabilities |
4,520,463,134.46 |
| Paid-In Capital(Or Share Stock) |
1,244,627,862.00 |
| Capital Surplus |
5,159,461,202.35 |
| Surplus Reserve |
82,582,724.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-303,072,476.90 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,185,876,952.97 |
| Owner's Equity（Stockholder's Equity） |
6,185,876,952.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,706,340,087.43 |
